Literature DB >> 3158613

N-ras gene activation in the RD human rhabdomyosarcoma cell line.

P Chardin, P Yeramian, P Madaule, A Tavitian.   

Abstract

A transforming N-ras allele was molecularly cloned from the RD human rhabdomyosarcoma cell line, and the nature of its activation studied. Construction of chimeric recombinants between the RD-transforming allele and a normal human allele enabled us to localize the alteration responsible for the activation to the second exon of the N-ras gene. The nucleotide sequence of this exon, when compared to that of the normal allele, revealed a single difference at the 61st amino acid position of the encoded protein; the CAA codon for glutamine in the normal allele was mutated to a CAT codon for histidine in the RD-transforming allele. This result is the first description of a histidine replacing glutamine in the 61st position and provides further evidence that the 61st amino acid is one of the preferential sites for N-ras activation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158613     DOI: 10.1002/ijc.2910350513

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways.

Authors:  Neerav Shukla; Nabahet Ameur; Ismail Yilmaz; Khedoudja Nafa; Chyau-Yueh Lau; Angela Marchetti; Laetitia Borsu; Frederic G Barr; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2011-12-05       Impact factor: 12.531

2.  FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.

Authors:  Lisa E S Crose; Katherine T Etheridge; Candy Chen; Brian Belyea; Lindsay J Talbot; Rex C Bentley; Corinne M Linardic
Journal:  Clin Cancer Res       Date:  2012-05-30       Impact factor: 12.531

3.  Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.

Authors:  Silvia Codenotti; Maura Poli; Michela Asperti; Daniela Zizioli; Francesco Marampon; Alessandro Fanzani
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-03       Impact factor: 4.553

4.  Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma.

Authors:  Francesca Bersani; Marcello Francesco Lingua; Deborah Morena; Valentina Foglizzo; Silvia Miretti; Letizia Lanzetti; Giovanna Carrà; Alessandro Morotti; Ugo Ala; Paolo Provero; Roberto Chiarle; Samuel Singer; Marc Ladanyi; Thomas Tuschl; Carola Ponzetto; Riccardo Taulli
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

5.  The ral gene: a new ras related gene isolated by the use of a synthetic probe.

Authors:  P Chardin; A Tavitian
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

6.  Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.

Authors:  Francesco Marampon; Carmela Ciccarelli; Bianca M Zani
Journal:  Mol Cancer       Date:  2006-08-09       Impact factor: 27.401

Review 7.  Rhabdomyosarcomas: an overview on the experimental animal models.

Authors:  Alessandra Zanola; Stefania Rossi; Fiorella Faggi; Eugenio Monti; Alessandro Fanzani
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

Review 8.  Caveolins in rhabdomyosarcoma.

Authors:  Stefania Rossi; Pietro Luigi Poliani; Cristina Missale; Eugenio Monti; Alessandro Fanzani
Journal:  J Cell Mol Med       Date:  2011-12       Impact factor: 5.310

9.  Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.

Authors:  K Kubo; T Naoe; K R Utsumi; Y Ishiguro; K Ueda; H Shiku; K Yamada
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

10.  Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma.

Authors:  Fiorella Faggi; Stefania Mitola; Guglielmo Sorci; Francesca Riuzzi; Rosario Donato; Silvia Codenotti; Pietro Luigi Poliani; Manuela Cominelli; Raffaella Vescovi; Stefania Rossi; Stefano Calza; Marina Colombi; Fabio Penna; Paola Costelli; Ilaria Perini; Maurilio Sampaolesi; Eugenio Monti; Alessandro Fanzani
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.